387
Views
4
CrossRef citations to date
0
Altmetric
REVIEW

Extensive-Stage Small-Cell Lung Cancer: Current Landscape and Future Prospects

, ORCID Icon & ORCID Icon
Pages 657-671 | Received 31 Mar 2023, Accepted 19 Jul 2023, Published online: 02 Aug 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Sukhvinder Johal, Lance Brannman, Victor Genestier & Hélène Cawston. (2024) Challenges with Estimating Long-Term Overall Survival in Extensive Stage Small-Cell Lung Cancer: A Validation-Based Case Study. ClinicoEconomics and Outcomes Research 16, pages 97-109.
Read now

Articles from other publishers (3)

Xudong Xiang, Heng Li, Bao Lei, Benchao Chen & Gaofeng Li. (2024) Serplulimab monotherapy in extensive-stage small-cell lung cancer with brain metastasis: a case report. Immunotherapy.
Crossref
Manyi Xu, Keda Shao, Yanhua Wang, Yue Hao & Zhengbo Song. (2024) Comparison of the efficacy and safety of anlotinib monotherapy or anlotinib plus immune checkpoint inhibitor for advanced small cell lung cancer with brain metastases. Clinical and Translational Oncology.
Crossref
Nesrin Irep, Kubilay Inci, Pervin Elvan Tokgun & Onur Tokgun. (2024) Exosome inhibition improves response to first‐line therapy in small cell lung cancer. Journal of Cellular and Molecular Medicine 28:4.
Crossref